Detalhe da pesquisa
1.
Neutralizing Antibody Validation Testing and Reporting Harmonization.
AAPS J
; 25(4): 69, 2023 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421491
2.
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy.
AAPS J
; 24(4): 76, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35725847
3.
Immunogenicity of panitumumab in combination chemotherapy clinical trials.
BMC Clin Pharmacol
; 11: 17, 2011 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22070868
4.
A method to quantitate the neutralizing capacity of anti-therapeutic protein antibodies in serum and their correlation to clinical impact.
J Pharm Biomed Anal
; 102: 176-83, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25279937
5.
Multiplexed evaluation of a cell-based assay for the detection of antidrug neutralizing antibodies to panitumumab in human serum using automated fluorescent microscopy.
J Biomol Screen
; 15(6): 644-52, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20508254
6.
Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab.
J Immunol
; 178(11): 7467-72, 2007 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17513798